apomorphine has been researched along with Adenoma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gardiner, RJ; Goodyer, CG; Guyda, H; Hardy, J; Marcovitz, S | 1 |
| Gurkalo, VK; Zabezhinskiĭ, MA | 1 |
| Bethea, CL; Jaffe, RB; Ramsdell, JS; Weiner, RI; Wilson, CB | 1 |
| Brandi, AM; Bression, D; Le Dafniet, M; Nousbaum, A; Peillon, F; Racadot, J | 1 |
| Malarkey, WB; Tallo, D | 1 |
| Bression, D; Martres, MP; Peillon, F | 1 |
| Hoyte, KM; Martin, JB | 1 |
| Bouvier, C; Collu, R; Lagacé, G; Potier, M | 1 |
8 other study(ies) available for apomorphine and Adenoma
| Article | Year |
|---|---|
Comparative study of human fetal, normal adult, and somatotropic adenoma pituitary function in tissue culture.
Topics: Adenoma; Adult; Apomorphine; Culture Techniques; Dose-Response Relationship, Drug; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Somatostatin; Thyrotropin-Releasing Hormone | 1982 |
[Effects of apomorphine and haloperidol on experimental hepatocarcinogenesis].
Topics: Adenoma; Adenoma, Bile Duct; Animals; Apomorphine; Cell Transformation, Neoplastic; Diethylnitrosamine; Haloperidol; Hemangioma; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Neoplasms, Experimental; Rats; Receptors, Dopamine | 1983 |
Characterization of the dopaminergic regulation of human prolactin-secreting cells cultured on extracellular matrix.
Topics: Adenoma; Adult; Apomorphine; Bromocriptine; Cells, Cultured; Dihydroergotoxine; Dopamine; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin | 1982 |
Evidence of dopamine receptors in human growth hormone (GH)-secreting adenomas with concomitant study of dopamine inhibition of GH secretion in a perifusion system.
Topics: Adenoma; Apomorphine; Domperidone; Dopamine; Dose-Response Relationship, Drug; Growth Hormone; Humans; Perfusion; Pituitary Neoplasms; Receptors, Dopamine | 1982 |
Adrenergic and dopaminergic modulation of growth hormone and prolactin secretion in normal and tumor bearing human pituitaries in monolayer culture.
Topics: Acromegaly; Adenoma; Adult; Apomorphine; Breast Neoplasms; Bromocriptine; Cells, Cultured; Dopamine; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Sympathomimetics | 1981 |
[Demonstration of dopaminergic receptors in human pituitary adenomas secreting prolactin].
Topics: Adenoma; Apomorphine; Benzimidazoles; Binding, Competitive; Humans; Kinetics; Piperidines; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Receptors, Dopamine | 1979 |
Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy.
Topics: Acromegaly; Adenoma; Adult; Apomorphine; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Insulin; Levodopa; Luteinizing Hormone; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone | 1975 |
Structural differences between dopamine D2 receptors present in a rat pituitary adenoma and in transplantable rat pituitary tumors 7315a and MtTW15.
Topics: Adenoma; Animals; Apomorphine; Binding, Competitive; Carrier Proteins; Chemical Phenomena; Chemistry; Dopamine Agents; Ethylmaleimide; Neoplasm Transplantation; Pituitary Neoplasms; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Solubility; Spiperone | 1990 |